In contrast, the SCN9A gain-of-function mutations cause genetic painful neuropathies such as small fiber neuropathy, primary erythromelalgia and paroxysmal extreme pain disorder (de Lera Ruiz and Kraus, 2015; Vetter et al., 2017). This evidence concerns the gene SCN9A and primary erythermalgia.